Business · Markets · 2 days ago
HAL’s large order book faces execution risks as its stock valuation stays high
Hindustan Aeronautics, or HAL, is an Indian aerospace and defence company that makes and maintains aircraft, helicopters and engines.
It entered FY27 with orders worth ₹2.54 trillion, and expects to secure another ₹90,000 crore in orders over the next two years.
To meet demand, it is expanding production and plans to invest about ₹12,000 crore in new facilities and projects by 2030.
The company’s prospects depend on turning its orders into products and delivering them on time.
That may be difficult because complex aircraft and helicopters rely on many components, including some sourced from abroad, and past delays in GE engine deliveries have affected execution.
HAL is debt-free and aims to maintain Ebitda margins of 30–31%, but its shares trade at 34.5 times earnings, leaving limited room for setbacks.
Over the next five years, timely delivery, production growth and supply-chain reliability will be important to the stock’s performance.
HAL entered FY27 with an order book of ₹2.54 trillion, supporting its long-term prospects.
Mint says the stock’s valuation of 34.5 times earnings leaves limited room for supply-chain bottlenecks and execution delays.
HAL expects to secure fresh orders worth ₹90,000 crore over the next two years, including repair and overhaul contracts.
The company is expanding production capacity and plans to invest about ₹12,000 crore in capital projects by 2030.
Its ability to deliver orders on time is a key factor in turning the order book into revenue.
- Who
- Hindustan Aeronautics (HAL), an Indian aerospace and defence company.
- What
- Its ₹2.54 trillion order book supports its outlook, but execution, supply-chain and valuation risks could weigh on performance.
- When
- HAL entered FY27 with the order book; the article examines prospects over the next five years.
- Where
- India.
- Why
- Delivering complex aircraft and defence programs on time is essential to convert orders into revenue, while the stock’s elevated valuation offers limited cushion against delays.
This story does not have two clearly opposing sides.
No direct quotes in the coverage so far.
This story does not have a timeline yet.
- Order book
- ₹2.54 trillion at the start of FY27
- Expected fresh orders
- ₹90,000 crore over the next two years
- Planned capital spending
- About ₹12,000 crore by 2030
- Valuation
- 34.5 times earnings
- Target EBITDA margin
- 30–31%

